Cargando…

Alternative RNA Splicing in Fatty Liver Disease

Alternative RNA splicing is a process by which introns are removed and exons are assembled to construct different RNA transcript isoforms from a single pre-mRNA. Previous studies have demonstrated an association between dysregulation of RNA splicing and a number of clinical syndromes, but the genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Panyisha, Zhang, Moya, Webster, Nicholas J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953061/
https://www.ncbi.nlm.nih.gov/pubmed/33716968
http://dx.doi.org/10.3389/fendo.2021.613213
_version_ 1783663856302686208
author Wu, Panyisha
Zhang, Moya
Webster, Nicholas J. G.
author_facet Wu, Panyisha
Zhang, Moya
Webster, Nicholas J. G.
author_sort Wu, Panyisha
collection PubMed
description Alternative RNA splicing is a process by which introns are removed and exons are assembled to construct different RNA transcript isoforms from a single pre-mRNA. Previous studies have demonstrated an association between dysregulation of RNA splicing and a number of clinical syndromes, but the generality to common disease has not been established. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease affecting one-third of adults worldwide, increasing the risk of cirrhosis and hepatocellular carcinoma (HCC). In this review we focus on the change in alternative RNA splicing in fatty liver disease and the role for splicing regulation in disease progression.
format Online
Article
Text
id pubmed-7953061
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79530612021-03-13 Alternative RNA Splicing in Fatty Liver Disease Wu, Panyisha Zhang, Moya Webster, Nicholas J. G. Front Endocrinol (Lausanne) Endocrinology Alternative RNA splicing is a process by which introns are removed and exons are assembled to construct different RNA transcript isoforms from a single pre-mRNA. Previous studies have demonstrated an association between dysregulation of RNA splicing and a number of clinical syndromes, but the generality to common disease has not been established. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease affecting one-third of adults worldwide, increasing the risk of cirrhosis and hepatocellular carcinoma (HCC). In this review we focus on the change in alternative RNA splicing in fatty liver disease and the role for splicing regulation in disease progression. Frontiers Media S.A. 2021-02-26 /pmc/articles/PMC7953061/ /pubmed/33716968 http://dx.doi.org/10.3389/fendo.2021.613213 Text en Copyright © 2021 Wu, Zhang and Webster http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wu, Panyisha
Zhang, Moya
Webster, Nicholas J. G.
Alternative RNA Splicing in Fatty Liver Disease
title Alternative RNA Splicing in Fatty Liver Disease
title_full Alternative RNA Splicing in Fatty Liver Disease
title_fullStr Alternative RNA Splicing in Fatty Liver Disease
title_full_unstemmed Alternative RNA Splicing in Fatty Liver Disease
title_short Alternative RNA Splicing in Fatty Liver Disease
title_sort alternative rna splicing in fatty liver disease
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953061/
https://www.ncbi.nlm.nih.gov/pubmed/33716968
http://dx.doi.org/10.3389/fendo.2021.613213
work_keys_str_mv AT wupanyisha alternativernasplicinginfattyliverdisease
AT zhangmoya alternativernasplicinginfattyliverdisease
AT websternicholasjg alternativernasplicinginfattyliverdisease